nach oben

International Journal of Clinical Oncology

Erschienen in:

01.06.2013 | Original Article

High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma

verfasst von: Jun Du, Jian-Hua Zheng, Xu-Sheng Chen, Qing Yang, Yan-Hui Zhang, Lei Zhou, Xin Yao

Erschienen in: International Journal of Clinical Oncology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to evaluate the association of preoperative plasma fibrinogen levels with the clinicopathological parameters, disease-free survival, and overall survival in patients with renal cell carcinoma.

Methods

We retrospectively studied 286 patients with renal cell carcinoma who underwent radical nephrectomy from 2000 to 2003 at one center. The plasma fibrinogen was routinely determined before operation in all patients. The correlation of preoperative plasma fibrinogen levels with clinicopathological findings was evaluated by t-test or analysis of variance (ANOVA) methods. As well, univariate and multivariate analyses were used to determine the association between the preoperative level of plasma fibrinogen and survival duration.

Results

An elevated level of plasma fibrinogen was positively related to the Fuhrman grade (P < 0.001), tumor size (P < 0.001), and T stage (P < 0.001), but it was negatively related to histologic type (P = 0.266). Univariate analysis showed that the Fuhrman grade, tumor size, T stage, hemoglobin, corrected calcium, lactate dehydrogenase, and plasma fibrinogen level were significantly correlated with disease-free survival (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P = 0.001, P < 0.001, and P < 0.001, respectively) and overall survival (P < 0.001, P = 0.001, P < 0.001, P < 0.001, P = 0.002, P = 0.001, and P < 0.001). Multivariate analysis showed that the plasma fibrinogen level remained as an independent prognostic factor for disease-free survival (P = 0.021) and overall survival (P < 0.001).

Conclusions

A high preoperative plasma fibrinogen level is an independent predictor of distant metastasis and survival prognosis after radical nephrectomy in patients with renal cell carcinoma.

Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31PubMed

Wang X, Wang E, Kavanagh JJ et al (2005) Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3:25PubMedCrossRef

Bardos H, Molnar P, Csecsei G et al (1996) Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul Fibrinolysis 7:536–548PubMedCrossRef

Dvorak HF, Nagy JA, Berse B et al (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 667:101–111PubMedCrossRef

Tennent GA, Brennan SO, Stangou AJ et al (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109:1971–1974PubMedCrossRef

Collen D, Tytgat GN, Claeys H et al (1972) Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Br J Haematol 22:681–700PubMedCrossRef

Koenig W (2003) Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89:601–609PubMed

Altieri DC, Mannucci PM, Capitanio AM (1986) Binding of fibrinogen to human monocytes. J Clin Invest 78:968–976PubMedCrossRef

Dejana E, Languino LR, Polentarutti N et al (1985) Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 75:11–18PubMedCrossRef

10.

Dvorak HF, Harvey VS, Estrella P et al (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57:673–686PubMed

11.

Gross TJ, Leavell KJ, Peterson MW (1997) CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 77:894–900PubMed

12.

Languino LR, Duperray A, Joganic KJ et al (1995) Regulation of leukocyte–endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 92:1505–1509PubMedCrossRef

13.

Robson SC, Saunders R, Purves LR et al (1993) Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood 81:3006–3014PubMed

14.

Gerner C, Steinkellner W, Holzmann K et al (2001) Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis. Thromb Haemost 85:494–501PubMed

15.

Palumbo JS, Potter JM, Kaplan LS et al (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62:6966–6972PubMed

16.

Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185PubMedCrossRef

17.

Palumbo JS, Kombrinck KW, Drew AF et al (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302–3309PubMed

18.

Cavanaugh PG, Sloane BF, Honn KV (1988) Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. Haemostasis 18:37–46PubMed

19.

Chew EC, Wallace AC (1976) Demonstration of fibrin in early stages of experimental metastases. Cancer Res 36:1904–1909PubMed

20.

Crissman JD, Hatfield JS, Menter DG et al (1988) Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48:4065–4072PubMed

21.

Hatzfeld JA, Hatzfeld A, Maigne J (1982) Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA 79:6280–6284PubMedCrossRef

22.

Pollanen J, Stephens RW, Vaheri A (1991) Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273–328PubMedCrossRef

23.

Yamashita H, Kitayama J, Kanno N et al (2006) Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6:147PubMedCrossRef

24.

Polterauer S, Seebacher V, Hefler-Frischmuth K et al (2009) Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer. Am J Obstet Gynecol 200(647):e641–e647

25.

Polterauer S, Grimm C, Seebacher V et al (2009) Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 14:979–985PubMedCrossRef

26.

Lopez Y, Paloma MJ, Rifon J et al (1999) Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 93:71–78PubMedCrossRef

27.

Kerlin B, Cooley BC, Isermann BH et al (2004) Cause-effect relation between hyperfibrinogenemia and vascular disease. Blood 103:1728–1734PubMedCrossRef

28.

Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59:1295–1300PubMed

29.

Yano HJ, Hatano K, Tsuno N et al (2001) Clustered cancer cells show a distinct adhesion behavior from single cell form under physiological shear conditions. J Exp Clin Cancer Res 20:407–412

30.

Yamashita H, Kitayama J, Nagawa H (2005) Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 35:595–600PubMedCrossRef

Titel: High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma
verfasst von: Jun Du
Jian-Hua Zheng
Xu-Sheng Chen
Qing Yang
Yan-Hui Zhang
Lei Zhou
Xin Yao
Publikationsdatum: 01.06.2013
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 3/2013
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-012-0412-x

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital

Comparison of pirarubicin-based versus gemcitabine–docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience

Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation

Old but new methods in radiation oncology: hyperbaric oxygen therapy

Old but new methods in radiation oncology

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie